Quantcast

Pharma news

Illumina buys Pacific Biosciences for $1.2 Billion

Illumina will acquire Pacific Biosciences for $1.2 billion, it was revealed on Friday, after the agreement had been approved by the board of directors of Illumina and Pacific Biosciences.

$ILMN $PACB

Posted in Approval, news | Tagged , | Leave a comment

Denali, Sanofi together developing RIPK1 inhibitors for treating neurological and inflammatory diseases

Denali Therapeutics will work with Sanofi on its multiple RIPK1 inhibitor molecules that could treat a range of neurological and systemic inflammatory diseases.

Posted in Approval, news | Tagged , , | Leave a comment

Price Increase on Calcium Carbonate products in US and Canada

Omya, a producer of industrial minerals informed Monday about a price increase of 7 – 9% for its Calcium Carbonate products in the US and Canada, from the start of the next year.

Posted in Approval, news | Tagged , | Leave a comment

N4 Pharma’s Nuvec can deliver system for vaccines and cancer treatments

@n4pharma with MedImmune UK, has been studying the level of immune response Nuvec can deliver when combined with a target antigen in a study using messenger RNA (mRNA) and plasmid DNA (pDNA) encoded with the standard test antigen Ovalbumin (OVA).

Posted in Approval, news | Tagged , | Leave a comment

Idifarma strengthens Palobiofarma relationship with seventh project

Spanish contract development and manufacturing organisation (CDMO) @Idifarma has begun its seventh project with Spanish biotechnology company, Palobiofarma.

Posted in Approval, news | Tagged | Leave a comment

LEH Pharma picks Syneos Health for better selling EyeMax lens

LEH Pharma, a provider of revolutionary ocular implants for macular disorders, has picked Syneos Health, a fully integrated biopharmaceutical solutions organization, as its Global Clinical Development and Commercialisation Provider.

Posted in Approval, news | Tagged , | Leave a comment

Hemogenyx, Orgenesis to market Hu-PHEC technology

Hemogenyx and Orgenesis have entered into collaboration on the further development of Human Postnatal Hemogenic Endothelial Cell technology

Posted in Approval, news | Tagged | Leave a comment

Foamix Pharma Releases positive phase 3 acne data; stock soars 50% in after hours

Foamix Pharmaceuticals showed its topline results of its third Phase 3 clinical trial (FX2017-22) of FMX101 for the treatment of moderate-to-severe acne.

Posted in Approval, news | Tagged , | Leave a comment

Karuna gets $42 million in financing round

PureTech Health and its affiliate Karuna have completed a $42 million Series A financing round, which will be used to

Posted in Approval, news | Tagged , | Leave a comment

Amryt’s Epidermolysis Bullosa treatment granted Rare Pediatric Disease from US FDA

Amryt ensure US Food and Drug Administration’s grant a Rare Pediatric Disease designation for its lead development asset AP101, for

Posted in Approval, news | Tagged , | Leave a comment